Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014–2015
Open Access
- 6 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 214 (7), 1010-1019
- https://doi.org/10.1093/infdis/jiw181
Abstract
Background. During the 2014–2015 US influenza season, expanded genetic characterization of circulating influenza A(H3N2) viruses was used to assess the impact of the genetic variability of influenza A(H3N2) viruses on influenza vaccine effectiveness (VE). Methods. A novel pyrosequencing assay was used to determine genetic group, based on hemagglutinin (HA) gene sequences, of influenza A(H3N2) viruses from patients enrolled at US Influenza Vaccine Effectiveness Network sites. VE was estimated using a test-negative design comparing vaccination among patients infected with influenza A(H3N2) viruses and uninfected patients. Results. Among 9710 enrollees, 1868 (19%) tested positive for influenza A(H3N2) virus; genetic characterization of 1397 viruses showed that 1134 (81%) belonged to 1 HA genetic group (3C.2a) of antigenically drifted influenza A(H3N2) viruses. Effectiveness of 2014–2015 influenza vaccination varied by influenza A(H3N2) virus genetic group from 1% (95% confidence interval [CI], −14% to 14%) against illness caused by antigenically drifted influenza A(H3N2) virus group 3C.2a viruses versus 44% (95% CI, 16%–63%) against illness caused by vaccine-like influenza A(H3N2) virus group 3C.3b viruses. Conclusions. Effectiveness of 2014–2015 influenza vaccination varied by genetic group of influenza A(H3N2) virus. Changes in HA genes related to antigenic drift were associated with reduced VE.Keywords
Funding Information
- CDC (U01IP000466, U01IP000467, U01IP000471, U01IP000473, and U01IP000474)
This publication has 30 references indexed in Scilit:
- Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to InfectionViruses, 2014
- Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus EvolutionScience, 2013
- Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on EstimatesClinical Infectious Diseases, 2013
- The case test-negative design for studies of the effectiveness of influenza vaccineVaccine, 2013
- The test-negative design for estimating influenza vaccine effectivenessVaccine, 2013
- WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011Vaccine, 2012
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2011
- Detection of Hemagglutinin Variants of the Pandemic Influenza A (H1N1) 2009 Virus by PyrosequencingJournal of Clinical Microbiology, 2011
- Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A VirusesJournal of Virology, 2009
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 SeasonThe Journal of Infectious Diseases, 2009